In 1971, a group of researchers founded the Monash IVF Research Program with the mission to discover how in vitro fertilization, or IVF, techniques could become a treatment for infertility in both men and women. The program included researcher Carl Wood and colleagues John Leeton, Alex Lopata, Alan Trounson, and Ian Johnston at the Queen Victoria Medical Center and Royal Women’s Hospital in Melbourne, Australia. Since the program’s establishment in 1971, the Monash IVF Research Program has helped to develop and implement many IVF technologies still used in clinical practice as of 2020. Additionally, the program established some of the first successful IVF pregnancies and births. As of 2020, the Monash IVF Research Program is one of Australia’s leading fertility programs and has used their technologies to help provide IVF treatment to thousands of infertile men and women.

Alan Osborne Trounson is a scientist from Australia who studies embryology and stem cells. His research has improved the success rates of in vitro fertilization, or IVF. IVF is a medical procedure in which scientists fertilize an egg cell with sperm outside of the body, often in a laboratory petri dish, then transfer the fertilized egg to a woman’s uterus to start pregnancy. Trounson also researched embryonic stem cells, or stem cells collected from embryos, and their potential for treating injuries and diseases. Additionally, Trounson led the Californian Institute for Regenerative Medicine, or CIRM, one of the largest agencies to fund stem cell research in California, from 2007 to 2014. Over the course of his career, Trounson developed several techniques that improved the effectiveness of IVF, including fertility treatments and cryopreservation, and supported stem cell research as a scientist and administrator.